Remdesivir Approval Expanded to Include COVID-19 Treatment in Younger Children
The approval was supported by data from a phase 2/3 CARAVAN study.
The approval was supported by data from a phase 2/3 CARAVAN study.
Researchers assessed risk factors and characteristics of a pediatric population with discoid lupus erythematosus and systemic lupus erythematosus.
This study was a cross-sectional analysis of data from the Youth Aware of Mental Health promotion program which took place in Texas.
Each doubling of serum perfluorooctanoate, overall PFAS/phthalate mixture linked to lower areal BMD in male adolescents
The U.S. Food & Drug Administration announced that it is continuing its efforts to boost the country’s supply of infant formula.
Researchers developed and validated a diagnostic prediction model to distinguish between juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome.
Later cisgender identities more common among youth with initial social transition before age 6 years.
Statistical shape modeling of ultrasound images of well-centered stable dysplastic hips in infants can predict persistent hip dysplasia that could benefit from treatment.
The submission includes data from a phase 2/3 clinical trial that assessed the safety, tolerability and immunogenicity of a third dose (10µg booster) in 140 children 5 to 11 years of age.
Children with a vegetarian diet have no evidence of differences in growth or biochemical measures of nutrition.